The Chase Group and Ionis Seek Subject Matter Expert, in Respiratory Drug Development, to Build Their New Program

December 18, 2017
The Chase Group (TCG) continues a strong relationship with Ionis, helping to build their organization. Ionis is committed and driven by the science and challenges teams to focus on patients who need their products. This new position is an exciting opportunity to champion Ionis’ first respiratory product, work with an impressive research team, and have a high level of visibility within the company. TCG is excited to represent this opportunity within the industry. For further information about The Chase Group and this opportunity, please contact karen@chasegroup.com.

Chase Group

Share this Content

Copyright © 1993-2024 The Chase Group. All Rights Reserved.